PDS Biotechnology (FRA:EU6) Cyclically Adjusted Book per Share: €13.65 (As of Mar. 2026)


FRA:EU6 PDS Biotechnology Corp FRA:EU6
32 GF Score
Price €0.75
! 1 Warning Sign
View Full Analysis

What is PDS Biotechnology Cyclically Adjusted Book per Share?

PDS Biotechnology FRA:EU6 -2.36% 32 Cyclically Adjusted Book per Share is €13.65 as of Mar. 2026. GuruFocus rates FRA:EU6 with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PDS Biotechnology's adjusted book value per share for the three months ended in Mar. 2026 was €0.060. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €13.65 for the trailing ten years ended in Mar. 2026.

During the past 12 months, PDS Biotechnology's average Cyclically Adjusted Book Growth Rate was -12.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-05), PDS Biotechnology's current stock price is €0.746. PDS Biotechnology's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €13.65. PDS Biotechnology's Cyclically Adjusted PB Ratio of today is 0.05.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PDS Biotechnology was 0.05. The lowest was 0.00. And the median was 0.00.


PDS Biotechnology  (FRA:EU6) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PDS Biotechnology's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.746/13.65
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PDS Biotechnology was 0.05. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PDS Biotechnology Cyclically Adjusted Book per Share Related Terms


PDS Biotechnology Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for PDS Biotechnology's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PDS Biotechnology Cyclically Adjusted Book per Share Chart

PDS Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 23.05 17.69

PDS Biotechnology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.13 19.37 19.61 17.69 13.65

FRA:EU6 vs LTRN, AURX, VERU: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, PDS Biotechnology's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PDS Biotechnology Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PDS Biotechnology's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PDS Biotechnology's Cyclically Adjusted PB Ratio falls into.


FRA:EU6
32GF Score
PDS Biotechnology Corp FRA:EU6
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PDS Biotechnology Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PDS Biotechnology's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.06/330.2130*330.2130
=0.060

Current CPI (Mar. 2026) = 330.2130.

PDS Biotechnology Quarterly Data

Book Value per Share CPI Adj_Book
201606 65.890 241.018 90.274
201609 60.083 241.428 82.178
201612 58.530 241.432 80.053
201703 50.679 243.801 68.641
201706 48.669 244.955 65.609
201709 40.593 246.819 54.308
201712 34.156 246.524 45.751
201803 22.990 249.554 30.421
201806 18.226 251.989 23.884
201809 16.957 252.439 22.181
201812 16.684 251.233 21.929
201903 4.182 254.202 5.432
201906 3.523 256.143 4.542
201909 2.680 256.759 3.447
201912 1.994 256.974 2.562
202003 1.173 258.115 1.501
202006 0.983 257.797 1.259
202009 1.183 260.280 1.501
202012 1.002 260.474 1.270
202103 0.919 264.877 1.146
202106 2.132 271.696 2.591
202109 2.028 274.310 2.441
202112 1.966 278.802 2.329
202203 1.783 287.504 2.048
202206 1.709 296.311 1.905
202209 1.670 296.808 1.858
202212 1.377 296.797 1.532
202303 1.247 301.836 1.364
202306 0.970 305.109 1.050
202309 0.740 307.789 0.794
202312 0.724 306.746 0.779
202403 0.933 312.332 0.986
202406 0.781 314.175 0.821
202409 0.538 315.301 0.563
202412 0.478 315.605 0.500
202503 0.455 319.799 0.470
202506 0.297 322.561 0.304
202509 0.169 324.800 0.172
202512 0.144 324.054 0.147
202603 0.060 330.213 0.060

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €13.65 mean?
PDS Biotechnology (FRA:EU6) has a Cyclically Adjusted Book per Share of €13.65 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PDS Biotechnology and its competitors.
Is PDS Biotechnology's Cyclically Adjusted Book per Share too high?
PDS Biotechnology's current Cyclically Adjusted Book per Share is €13.65. Overall, PDS Biotechnology has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does PDS Biotechnology's Cyclically Adjusted Book per Share compare to LTRN and AURX?
PDS Biotechnology's Cyclically Adjusted Book per Share of €13.65 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PDS Biotechnology and its competitors. PDS Biotechnology's current Cyclically Adjusted Book per Share is €13.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PDS Biotechnology stock overvalued right now?
PDS Biotechnology (FRA:EU6) has a current Cyclically Adjusted Book per Share of €13.65. The current Cyclically Adjusted Book per Share is €13.65. PDS Biotechnology's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For PDS Biotechnology (FRA:EU6), the current Cyclically Adjusted Book per Share is €13.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PDS Biotechnology Business Description

Other Exchanges PDSB:USA
Address 303A College Road, East Princeton, NJ, USA, 08540
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
32GF Score

Get the complete analysis for FRA:EU6

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.75
Price